About Us

Archives






Dave Johnson Joins Biosplice Therapeutics Board of Directors

Posted: June 22, 2021 at 1:49 am


SAN DIEGO, June 21, 2021 (GLOBE NEWSWIRE) -- Biosplice Therapeutics, Inc. (“Biosplice”), a clinical-stage biotechnology company pioneering therapeutics based on alternative pre-mRNA splicing for major diseases, announced today the addition of Dave Johnson, most recently Founder and CEO of VelosBio, as an independent director to its board.

Read the rest here:
Dave Johnson Joins Biosplice Therapeutics Board of Directors

Related Post

No Comments

No comments yet.

Sorry, the comment form is closed at this time.